Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

Dr. Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

New York University | United States

Dr. Aasma Shaukat, M.D., M.P.H., is an internationally acclaimed gastroenterologist, epidemiologist, and academic leader recognized for her transformative contributions to colorectal cancer prevention, gastrointestinal outcomes research, and population health. She serves as Director of Gastrointestinal Outcomes Research, Robert M. and Mary H. Glickman Endowed Professor of Medicine, Professor of Population Health, Co-Director of the Translational Research Education and Career (TREC) Program, and Program Director for the KL2 Scholars Program at the Clinical and Translational Science Institute at NYU Grossman School of Medicine, while also serving as a staff physician at the VA New York Harbor Healthcare System. Before joining NYU, she led the Gastroenterology Section at the Minneapolis VA Health Care System and was a core investigator at the Center for Chronic Disease Outcomes Research, establishing herself as a national authority in outcomes-based gastroenterology. Dr. Shaukat holds an M.B., B.S. from The Aga Khan University Medical College in Karachi and an M.P.H. in International Health and Epidemiology from Johns Hopkins Bloomberg School of Public Health, followed by residency training in Internal Medicine at the State University of New York and fellowship training in Gastroenterology at Emory University School of Medicine. Board-certified in Internal Medicine and Gastroenterology, she has combined clinical expertise with advanced epidemiologic research to drive evidence-based improvements in digestive health and preventive care. Her research has shaped international colorectal cancer screening practices through landmark studies demonstrating the long-term mortality benefit of fecal occult blood testing, influencing screening guidelines worldwide. With more than 273 peer-reviewed publications and numerous invited lectures, Dr. Shaukat has become one of the most cited researchers in gastroenterology, with an h-index of 50, i10-index of 155, and over 9,245 citations according to Scopus, underscoring her scientific impact. Her work encompasses endoscopic quality improvement, health disparities, cost-effectiveness of screening programs, and novel noninvasive diagnostics for gastrointestinal diseases. In addition to her research, Dr. Shaukat is a dedicated mentor and educator who has guided countless trainees and junior faculty, championing diversity and inclusion in academic medicine. She serves on the Board of Trustees for the American College of Gastroenterology, chairs the Clinical Practice Section of the American Gastroenterological Association Institute, and contributes to several national advisory and planning committees, including ASCO GI, GIQUIC, PCORI, and the VA GI Field Advisory Board. A recipient of numerous prestigious honors such as the ASGE Endoscopic Research Mentoring Award, ACG MVP SCOPY Award for Colon Cancer Prevention, and NYU Research Mentor of the Year Award, she continues to shape the future of gastroenterology through innovation, mentorship, and leadership. Dr. Shaukat’s enduring legacy lies in her ability to merge clinical excellence, epidemiologic insight, and translational impact to advance gastrointestinal health globally and inspire the next generation of physician-scientists committed to research-driven healthcare transformation.

Profiles: Scopus Google Scholar | Orcid

Featured Publications

Udaikumar, J., Nimmagadda, Shaukat, A.,R., Ingawale, S., Lella, V. V., Vijayakumar, K., et al. (2025). Current perspectives on colorectal cancer screening and surveillance in the geriatric population. Current Gastroenterology Reports, 27(1), 34.

Singal, A. G., Quirk, L., Boike, J., Chernyak, V., Feng, Z., Giamarqo, G., Kanwal, F., … (2025). Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology, 82(3), 794–809.

Shaukat, A., Hu, J., Zhao, Y., Faulx, G., Augustin, A., Murphy, S., Stevens, E., et al. (2025). A randomized clinical trial of multi-level intervention to improve colorectal cancer screening rates at multiple federally qualified health care centers in New York City. Contemporary Clinical Trials, 108115.

Farooque, U., Murtaza, M., Umer, M., Johar, A., Aparna, F., Khan, A. R., Kumar, A., et al. (2025). Advancing health equity through telehealth: A systematic review and meta-analysis of remote vs. in-person weight-loss interventions among Black women with obesity. Current Obesity Reports, 14(1), 72.

Tang, C. Z., Delau, O. R., Katz, S., Axelrad, J. E., Hudesman, D., Shaukat, A., et al. (2025). Mild endoscopic disease activity is associated with adverse outcomes among older adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.

Gang Yang | Statistical Genetics and Genomics | Best Researcher Award

Prof. Gang Yang | Statistical Genetics and Genomics | Best Researcher Award

The First Hospital of Lanzhou University | China

Prof. Gang Yang is a distinguished Professor based in China, currently affiliated with The First Hospital of Lanzhou University, with a major research focus on cerebrovascular disease and glioma. Over his academic career, he has made sustained contributions to understanding molecular mechanisms and clinical implications in neurovascular and neuro-oncology fields. His representative works include: “HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway” published in Biochemical Pharmacology, “EPS8 is a Potential Oncogene in Glioblastoma” in OncoTargets and Therapy, “Identifying the role of aging-related genes in intracranial aneurysms through bioinformatics analysis” in Chinese Neurosurgical Journal, “Revisiting sinking skin flap syndrome: a series of case reports and literature review on cranioplasty with PEEK implants” in Neurological Research, and “Ferroptosis in early brain injury after subarachnoid hemorrhage: review of literature” in Chinese Neurosurgical Journal. His body of work interweaves molecular biology, signaling pathways, bioinformatics, and translational neurosurgical topics, with a particular emphasis on how genes such as EPS8 drive glioblastoma progression and how neurovascular injury processes involve oxidative stress and ferroptotic pathways. He is also active in reporting clinical neurosurgical phenomena such as sinking skin flap syndrome and exploring genetic and aging mechanisms underlying aneurysm development, reflecting his dual interest in both basic and clinical neuroscience. Professor Yang’s academic record demonstrates a profound commitment to bridging laboratory findings with clinical applications, enhancing diagnosis, and therapeutic strategies for brain tumors and cerebrovascular conditions. He has authored 8 peer-reviewed publications, which have collectively received 63 citations, resulting in an h-index of 4. His expertise in molecular oncology, vascular neurosurgery, and bioinformatics establishes him as a leading figure in cerebrovascular and glioma research both nationally and internationally.

Profiles: Scopus 

Featured Publications

Kang, J., Xu, X., Tian, S., & Yang, G. (2025). Revisiting sinking skin flap syndrome: A series of case reports and literature review on cranioplasty with PEEK implants. Neurological Research, 47(2), 1–7.